כל המחקרים
גיוסשלב II ושלב III (משולב)התערבותי

Evasayil TM: A placebo-controlled trial to evaluate the efficacy and safety of spesolimab in the treatment of patients with Netherton syndrome

This research study is looking into a new medicine called spesolimab (also known by its trial code BI 655130) for people with Netherton syndrome. Netherton syndrome is a rare genetic skin condition. The study aims to find out if spesolimab is effective at treating the symptoms of Netherton syndrome and if it is safe to use. To do this, some participants will receive the active medicine, while others will receive a 'dummy' treatment called a placebo, which looks just like the real medicine but contains no active drug. Researchers will compare the groups to understand the medicine's effects. The study will measure improvements in skin symptoms, as well as how participants feel in terms of pain, itch, and their daily lives. It's an important step in finding better ways to manage Netherton syndrome.

במבט חטוף

סטטוס
גיוס
שלב
שלב II ושלב III (משולב)
נותן חסות
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A., Boehringer Ingelheim RCV GmbH & Co. KG
יעד הרשמה
20
התחל
25 Apr 2023

על מה המחקר הזה?

This study is about a new medicine called spesolimab (also known as BI 655130) for a rare skin condition called Netherton syndrome. Netherton syndrome is a lifelong condition that causes very dry, red, and flaky skin, often with severe itching and other problems. Because it's a genetic condition, people are born with it.

The main goal of this study is to see if spesolimab can make a real difference to the skin symptoms of people living with Netherton syndrome and if it is safe to use. Researchers want to find out if the medicine can reduce the severity of the skin problems by at least half. They will also be looking at other important things, like how much pain and itching people experience, how much the condition affects their daily lives, and if there are any side effects from the treatment.

To make sure the results are reliable, some participants will receive the active medicine, spesolimab, while others will get a 'placebo.' A placebo is a treatment that looks exactly like the real medicine but doesn't contain any active drug. This helps scientists compare the effects of the actual medicine against no treatment, so they can be sure any improvements are due to spesolimab and not just chance. Finding new, effective, and safe treatments could significantly improve the lives of people with Netherton syndrome.

נקודות עיקריות

  • This study is testing a new medicine (spesolimab) for Netherton syndrome.
  • It aims to see if the medicine is effective and safe for people with the condition.
  • Some participants will receive the active medicine; others will receive a placebo.
  • The study measures improvements in skin symptoms, pain, itch, and quality of life.
  • It's open to adults aged 18 and over.
  • ההשתתפות כוללת ביקורים סדירים במרפאה ומעקב.

מי עשוי להיות זכאי?

To join this study, you need to be an adult, aged 18 years or older. The study is open to both men and women.

There will be other, more detailed requirements that you'd need to discuss with your doctor or the study team. These might include things like your current health, any other medicines you're taking, or how stable your Netherton syndrome is right now. These rules are in place to help make sure the study is as safe as possible for everyone involved and that the results are clear and accurate.

האם מחקר זה יכול להתאים לך?

ענה על השאלות המהירות הללו כדי לבדוק אם אתה עשוי להיות זכאי. זהו מדריך בלבד — צוות המחקר מקבל את ההחלטה הסופית.

  1. האם אתה בן 18 או יותר?
  2. Do you have a diagnosis of Netherton syndrome?
  3. Are you able to travel to study appointments?
  4. Are you willing to potentially receive a placebo?
  5. Are you currently in a stable health condition (not including your Netherton syndrome)?
ענה על כל שאלה כדי לראות את התוצאה שלך.

מה כרוך בהשתתפות?

Taking part in this study means you would receive either the study medicine (spesolimab) or a placebo (dummy treatment), given as an injection or infusion. You would have regular visits to the clinic so the study team can monitor your health, check your skin, and see how you're responding to the treatment. These visits will involve various tests and assessments, such as looking at your skin, asking about your pain and itch, and how it impacts your daily life. The study will last for a period of time, which the study team will explain to you in detail. There will also be follow-up appointments after you finish taking the study medicine to make sure you're doing well.

סיכונים ותועלות פוטנציאליים

Participating in a study like this could offer potential benefits, such as gaining access to a new medicine before it's widely available, and helping others by contributing to scientific knowledge. However, there are also potential risks, like experiencing side effects from the medicine or having to attend frequent clinic visits. You will be closely monitored for any unwanted effects and have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (11)

חלק מהמיקומים באתר הם משוערים. אנחנו עובדים על שיפור זה — אנא ודאו עם צוות הניסוי לפני הנסיעה.
  • —
    לא מאומת
    ספרד
  • —
    לא מאומת
    בלגיה
  • —
    לא מאומת
    בולגריה
  • —
    לא מאומת
    גרמניה
  • —
    לא מאומת
    איטליה
  • —
    לא מאומת
    פינלנד
  • —
    לא מאומת
    פורטוגל
  • —
    לא מאומת
    צ'כיה
  • —
    לא מאומת
    אוסטריה
  • —
    לא מאומת
    הולנד
  • —
    לא מאומת
    צרפת

שאלות נפוצות

What is Netherton syndrome?

Netherton syndrome is a rare genetic skin condition that causes chronic red, scaly skin, severe itching, and hair abnormalities.

What is spesolimab?

Spesolimab is a new medicine being tested to see if it can help improve the skin symptoms of Netherton syndrome.

מהו 'פלצבו'?

A placebo is a 'dummy' treatment that looks like the real medicine but contains no active drug. It helps researchers compare the effects of the actual medicine.

האם אדע אם אני מקבל את התרופה האמיתית או את הפלצבו?

Usually, in this type of study, neither you nor your doctor will know if you're getting the active medicine or the placebo until the study is over. This is called 'blinding' and helps ensure fair results.

כמה זמן נמשך המחקר?

The full duration of the study, including treatment and follow-up, will be explained in detail by the study team if you are interested in participating.

כיצד לגלות עוד

תמיד התייעץ עם רופא המשפחה או המומחה שלך לפני שתחליט להשתתף במחקר.

מעוניינים להשתתף?

רשום את התעניינותך

שתף את הפרטים שלך וצוות המחקר עבור "Evasayil TM: A placebo-controlled trial to evaluate the effi…" ייצרו איתך קשר אם אתה עשוי להיות זכאי. תמיד התייעץ עם הרופא שלך לפני שאתה מסכים להשתתף.

דיון

דיון קהילתי

מופעל על ידי הפורום שלנו ב community.patient.info. אנא היו מכבדים — זה אינו ייעוץ רפואי.